Sources
Loading...
Additional media
Loading...

Guardant Health ($GH) has reported its third quarter 2024 financial results and increased its 2024 revenue guidance. The company's stock saw an 18.4% increase in pre-market trading following the announcement, according to BW.


Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance https://t.co/qRT7AXcICf https://t.co/ynUz9w7wC4
$GH (+18.4% pre) Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance - BW https://t.co/sDGNu8DLXo
$GH 🇺🇸 Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance https://t.co/HviO0hgRoz https://t.co/DX0Mmaq1hJ